other trials13 Apr 2018 20:28
Unless I am mistaken, we have still not heard about the trials for asthma and mosquito illness....... strange that these highlights from the Sept report indicate end of year results, yet I do not think they have said anything yet....... confirm anyone?
B
Initiated a first-in-man Phase I study for Imutex's mosquito-borne illness vaccine platform (AGS-v) with NIAID expected to be completed at year end.
� Announced PrEP-001 Phase IIa dosing and asthma study results. Analysis of PrEP-001 potential asthma responder groups is underway with results expected at year end.